TARA FLANAGAN: Open Payments
NPI 1275925125 · MONTGOMERY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,008 in 88 payments from 25 companies in 2025. Trend: 2023 $2,982 · 2024 $2,675 · 2025 $2,008
Food & beverage: $2,008
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $313 |
| Lilly USA, LLC | 10 | $171 |
| Otsuka America Pharmaceutical, Inc. | 7 | $163 |
| PFIZER INC. | 7 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $141 |
| Amgen Inc. | 9 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $100 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
Products named: TEZSPIRE, JARDIANCE, REXULTI, OTEZLA, CAPLYTA, XIFAXAN, Auvelity, Kerendia.
Industry payments across NY — which companies pay providers there.
